Latest Regulatory News

Kinterra Capital has lodged a formal application with the Takeovers Panel, contesting Central Asia Metals’ takeover tactics and $10 million placement in New World Resources. The dispute raises questions about market fairness and control of the mineral explorer.

TechGen Metals has secured a Heritage Protection Agreement with the Jaru People, unlocking exploration licence grants and enabling planned drilling at its Blue Devil copper-gold-silver project in Western Australia.

Horseshoe Metals has secured crucial Direct Shipping Ore mining approval for its Horseshoe Lights Copper-Gold Project, setting the stage for imminent production and early revenue generation from high-grade copper stockpiles.

Vitasora Health has secured approximately A$11 million in capital to accelerate its expansion in the US remote patient monitoring market, highlighted by an upgraded contract with TPAC covering 15,000 patients. The company targets a USD 18 million annual recurring revenue run-rate by late 2026.

Horseshoe Metals secures $851,000 through a share placement and converts nearly $650,000 of debt into equity, aiming to accelerate development at its Horseshoe Lights Copper-Gold Project and fund exploration across Australia.

Prescient Therapeutics has opened a Share Purchase Plan to raise up to $7 million, offering shareholders discounted shares to fund the Phase 2 development of its targeted cancer therapy PTX-100.

Findi Limited is applying for two key licences from the Reserve Bank of India to expand its digital payments footprint, aiming to bridge the gap between cash and digital economies across India.

Enova Mining has launched a focused Phase 2 surface sampling campaign at its East Salinas project in Brazil, aiming to refine high-grade rare earth element drill targets ahead of planned drilling later this month.

Santana Minerals’ subsidiary has agreed to acquire Ardgour Station land for NZ$25 million, a move that clears the way for critical infrastructure at the Bendigo-Ophir Gold Project and removes a costly royalty burden.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

Helia Group reveals ING Bank Australia will not renew its Lenders Mortgage Insurance contract beyond June 2026, prompting a strategic business review amid evolving market dynamics.

Astron Corporation Limited proposes to shift its corporate domicile from Hong Kong to Australia by establishing a new Australian parent company, Astron Limited. Shareholders and CDI holders will exchange their securities on a two-for-one basis, aligning the group’s structure with its Australian assets and simplifying governance.